ClinicalTrials.gg
Drug

Sacubitril clinical trials

Also written AHU377.

studies test it
48
open now
12
in phase 3
14
first study started
2007

How each study uses sacubitril is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the sacubitril studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
7 Jul 2015 · ENTRESTO · NDA 207620 (FDA, Drugs@FDA; in a combination)
European Union
19 Nov 2015 · Entresto · EMEA/H/C/004062 (EMA; in a combination)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Development codes

AHU377
2

In one entry with another drug

Given together, or one or the other

sacubitril/valsartan
26
Sacubitril / Valsartan Oral Tablet
6
Sacubitril / Valsartan
4
Pharmacological
3
Experimental: Sacubitril/Allisartan and Amlodipine Group
2
sacubitril/ valsartan
2

Studies by the year they started

48 studies that test it; most in 2019 (6)

Studies that test sacubitril, by start year
YearStudies
20071
20111
20164
20173
20183
20196
20206
20215
20224
20234
20243
20255
20263

By phase

A phase 1/2 study counts in both.

Phase 1
1
Phase 2
9
Phase 3
14
Phase 4
20
No phase
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 10 · Other 38

Novartis Pharmaceuticals (8) · Shenzhen Salubris Pharmaceuticals Co., Ltd. (2) · Ruijin Hospital (2) · Brigham and Women's Hospital (2) · RenJi Hospital (2) · National Heart Institute, Egypt (1) · University Clinical Hospital Mostar (1) · Torbjorn Omland (1)

Often tested with

Tested in the same studies.

Valsartan (44) · Losartan (3) · Amlodipine (2) · Sacubitril valsartan sodium hydrate (2) · Sacubitril valsartan (2) · Bisoprolol (2) · Nebivolol (1) · Carvedilol (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 4, 1 in phase 3

Studies that test sacubitril, phase 3 first.

Studies

Open first, then newest update. How each study uses sacubitril is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 48

See all 48 studies that test sacubitril →

Given beside what is tested · 3 — sacubitril is usual care or a partner of the new treatment
As the comparator · 4 — what is tested is compared with sacubitril

Codes

What other systems call sacubitril · ClinicalTrials.gg INT001624

  • MeSH (NLM) C000717211sacubitrilOne source NLM
  • UNII (FDA) 17ERJ0MKGISACUBITRILConfirmed FDA, NLM, Wikidata
  • RxNorm 1656328Confirmed FDA, Wikidata
  • Wikidata Q17811448sacubitrilConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C152281SacubitrilOne source FDA
  • DrugBank DB09292One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.